<s> On the antiarrhythmic activity of one N-substituted Doc_44072_52_62_Chemical derivative of Doc_44072_77_134_Chemical. </s>
<s> The antiarrhythmic activity of the compound Doc_44072_180_288_Chemical, referred to as Doc_44072_305_308_Chemical, is studied on anaesthesized cats and Wistar albino rats, as well as on non-anaesthesized rabbits. </s>
<s> Four types of experimental Doc_44072_435_445_Disease are used--with Doc_44072_461_466_Chemical, with Doc_44072_473_483_Chemical-Doc_44072_484_494_Chemical, with Doc_44072_501_515_Chemical and with Doc_44072_525_534_Chemical. </s>
<s> The compound Doc_44072_549_552_Chemical is introduced in doses of 0.25 and 0.50 mg/kg intravenously and 10 mg/kg orally. </s>
<s> The compound manifests antiarrhythmic activity in all models of experimental Doc_44072_711_721_Disease used, causing greatest inhibition on the Doc_44072_763_773_Disease induced by Doc_44072_785_795_Chemical-Doc_44072_796_806_Chemical (in 90 per cent) and with Doc_44072_833_838_Chemical (in 84 per cent). </s>
<s> The results obtained are associated with the beta-adrenoblocking and with the membrane-stabilizing action of the compound. </s>
